Stock Research for CPIX


Featured Broker: Ally Invest

Get the due diligence for another stock.


CPIX Stock Chart & Research Data

The CPIX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CPIX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CPIX Due diligence Resources & Stock Charts

The CPIX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CPIX Detailed Price Forecast - CNN Money CNN View CPIX Detailed Summary - Google Finance
Yahoo View CPIX Detailed Summary - Yahoo! Finance Zacks View CPIX Stock Research & Analysis -

Stock Analysis

TradeIdeas View CPIX Trends & Analysis - Trade-Ideas Barrons View CPIX Major Holders - Barrons
NASDAQ View CPIX Call Transcripts - NASDAQ Seeking View CPIX Breaking News & Analysis - Seeking Alpha
Spotlight View CPIX Annual Report - OTC Report View CPIX OTC Short Report -
TradeKing View CPIX Fundamentals - TradeKing Charts View CPIX SEC Filings - Bar Chart
WSJ View Historical Prices for CPIX - The WSJ Morningstar View Performance/Total Return for CPIX - Morningstar
MarketWatch View the Analyst Estimates for CPIX - MarketWatch CNBC View the Earnings History for CPIX - CNBC
StockMarketWatch View the CPIX Earnings - StockMarketWatch MacroAxis View CPIX Buy or Sell Recommendations - MacroAxis
Bullish View the CPIX Bullish Patterns - American Bulls Short Pains View CPIX Short Pain Metrics -

Social Media Mentions

StockTwits View CPIX Stock Mentions - StockTwits PennyStocks View CPIX Stock Mentions - PennyStockTweets
Twitter View CPIX Stock Mentions - Twitter Invest Hub View CPIX Investment Forum News - Investor Hub
Yahoo View CPIX Stock Mentions - Yahoo! Message Board Seeking Alpha View CPIX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CPIX - Insider Cow View Insider Transactions for CPIX - Insider Cow
CNBC View CPIX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CPIX - OTC Markets
Yahoo View Insider Transactions for CPIX - Yahoo! Finance NASDAQ View Institutional Holdings for CPIX - NASDAQ

Stock Charts

FinViz View CPIX Stock Insight & Charts - StockCharts View CPIX Investment Charts -
BarChart View CPIX Stock Overview & Charts - BarChart Trading View View CPIX User Generated Charts - Trading View

Latest Financial News for CPIX

Cumberland Pharmaceuticals Expands into Oncology Support
Posted on Monday April 09, 2018

NASHVILLE, Tenn., April 9, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals – announced today that it has expanded its medical specialties to include oncology-related medications. "Since the company's founding, Cumberland has endeavored to deliver high quality medicines to improve patient care," said CEO AJ Kazimi. As a result, quality of life becomes of paramount concern – and Cumberland's focus is on supporting cancer patients during their treatment, with the goal of improving their ongoing quality of life.

Why Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) Ownership Structure Is Important
Posted on Thursday March 29, 2018

Today, I will be analyzing Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) recent ownership structure, an important but not-so-popular subject among individual investors. Ownership structure has been found to have an impact onRead More...

Newly Published Data Demonstrates 85% Eradication of Ulcer Causing Bacteria
Posted on Monday March 26, 2018

NASHVILLE, Tenn., March 26, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (CPIX), a U.S. specialty pharmaceutical company announced today the publication of an open access article in Infection and Drug Resistance, with results demonstrating an 85% eradication rate of Helicobacter pylori (H. pylori) infection using clarithromycin-based triple therapy. Cumberland markets a branded clarithromycin-based triple therapy in the U.S. under the name Omeclamox®-Pak. H. pylori has long been known as a common pathogen associated with gastric ulcers and related dyspeptic symptoms in many infected patients.

Edited Transcript of CPIX earnings conference call or presentation 6-Mar-18 9:30pm GMT
Posted on Wednesday March 07, 2018

Q4 2017 Cumberland Pharmaceuticals Inc Earnings Call

Enter a stock symbol to view the stock details.